Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer.
about
Mitochondria, cholesterol and cancer cell metabolismCancer drug resistance: redox resetting renders a wayIncreased Oxidative Stress as a Selective Anticancer TherapyTargeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphomaROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway.The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer.MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity.The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapy.Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer.Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells resistance through the CXCR4-SDF-1α signaling axis.
P2860
Q26741708-DD922FCF-2B53-48DA-BC5F-0114348C1E9DQ26750753-C74C1C50-0910-4902-BC39-9D86C03376CEQ26798210-81CBB4ED-D498-4E81-ABB7-D01E4D55CEB3Q30409463-9FCB759F-B021-4581-96E8-53F4E28D0772Q33560337-261D7F86-DB5F-4B3D-BB76-B280A20A0A41Q34279067-1CEABE93-D123-4F3E-83D0-92CD46A43633Q35907145-CD6B65F7-24A2-49E1-9D7F-B48AEB8726CEQ37348076-612244A4-154C-4B10-A815-FBDAC82FCA82Q37705942-CA059667-B117-4DA2-A624-9C0E3B382C36Q38318217-B534D60A-C44F-4CC4-815F-10AEE094C36EQ38738485-9D6EABAE-C545-4EEF-945B-33259AAA0528Q39020120-9CF55B9E-46D6-418F-B556-C03F2A1A8B78Q39670791-4C8ED302-2729-4334-9600-8852587D5C6DQ42121985-016D6E2F-8BEB-4D49-AE08-6A2F91BCBEDC
P2860
Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Potential use of the anti-infl ...... therapy of pancreatic cancer.
@ast
Potential use of the anti-infl ...... therapy of pancreatic cancer.
@en
type
label
Potential use of the anti-infl ...... therapy of pancreatic cancer.
@ast
Potential use of the anti-infl ...... therapy of pancreatic cancer.
@en
prefLabel
Potential use of the anti-infl ...... therapy of pancreatic cancer.
@ast
Potential use of the anti-infl ...... therapy of pancreatic cancer.
@en
P2093
P2860
P356
P1433
P1476
Potential use of the anti-infl ...... d therapy of pancreatic cancer
@en
P2093
P2860
P356
10.3747/CO.V17I3.485
P577
2010-06-01T00:00:00Z